TELA Bio
TELA
49 hedge funds and large institutions have $126M invested in TELA Bio in 2020 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 19 increasing their positions, 2 reducing their positions, and 6 closing their positions.
850% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 2
350% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 6
149% more capital invested
Capital invested by funds: $50.7M → $126M (+$75.5M)
69% more funds holding
Funds holding: 29 → 49 (+20)
10.63% more ownership
Funds ownership: 56.93% → 67.56% (+11%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
+$6.93M |
| 2 |
SAM
Silvercrest Asset Management
New York
|
+$4.27M |
| 3 |
EWM
Essex Woodlands Management
The Woodlands,
Texas
|
+$4.17M |
| 4 |
BlackRock
New York
|
+$3.31M |
| 5 |
SMH
Sanders Morris Harris
Houston,
Texas
|
+$3.23M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$1.3M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
-$315K |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$161K |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$161K |
| 5 |
DTL
Dynamic Technology Lab
Singapore
|
-$106K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WP
51
Woodline Partners
San Francisco,
California
| – | -$315K | -40,238 | Closed |
|
|
CS
52
Credit Suisse
Zurich,
Switzerland
| – | -$161K | -20,600 | Closed |
|
|
53
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$161K | -20,600 | Closed |
|
|
DTL
54
Dynamic Technology Lab
Singapore
| – | -$106K | -13,492 | Closed |
|
55
Victory Capital Management
San Antonio,
Texas
| – | -$12K | -1,422 | Closed |
|
TELA Hedge Fund Activity: Q2 2020 in Review
49 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in TELA Bio (TELA) for Q2 2020, worth a combined $126M — up 149% from $50.7M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new TELA positions and 6 closed out — a net gain of 21 holders — while 19 added to existing stakes and 2 trimmed.
The largest buyer was Alyeska Investment Group, adding an estimated $6.93M. The largest seller was Federated Hermes, exiting entirely with an estimated $1.3M sold.
- 49 institutional investors held TELA Bio (TELA) as of Q2 2020, up from 29 in Q1 2020.
- Funds reported $126M of TELA Bio stock for Q2 2020, up 149% quarter-over-quarter.
- 27 funds opened new TELA Bio positions in Q2 2020 and 6 closed out, a net change of +21 holders.
- The largest TELA Bio buyer in Q2 2020 was Alyeska Investment Group, an estimated $6.93M added.
- The largest TELA Bio seller in Q2 2020 was Federated Hermes, an estimated $1.3M sold.
Based on aggregated 13F filings for Q2 2020.